Anne Marquet

979 total citations
10 papers, 218 citations indexed

About

Anne Marquet is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Anne Marquet has authored 10 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Genetics and 2 papers in Neurology. Recurrent topics in Anne Marquet's work include Neurogenetic and Muscular Disorders Research (7 papers), RNA modifications and cancer (4 papers) and Cancer-related gene regulation (3 papers). Anne Marquet is often cited by papers focused on Neurogenetic and Muscular Disorders Research (7 papers), RNA modifications and cancer (4 papers) and Cancer-related gene regulation (3 papers). Anne Marquet collaborates with scholars based in Switzerland, Germany and United Kingdom. Anne Marquet's co-authors include Omar Khwaja, Christian Czech, Heidemarie Kletzl, Andreas Johne, Tobias Bergauer, Sonja Krösser, Katja Heinig, Nicolas Frances, Alain Patat and Andreas Guenther and has published in prestigious journals such as Cellular and Molecular Life Sciences, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

Anne Marquet

9 papers receiving 211 citations

Peers

Anne Marquet

GENET

SURGE

NEURO

PHARM

Céline Desseille France

Stéphanie Delstanche Belgium

Thomas Arnoux France

Emanuela Abiusi Italy

Arseniy Lavrov United Kingdom

Alessandro Introna Italy

Vasantha Gowda United Kingdom

Gregory Moy United States

Ludo van der Pol Netherlands

Céline Desseille France

Anne Marquet

78 ×0.5

90 ×0.7

GENET

21 ×0.3

SURGE

38 ×1.1

NEURO

2 ×0.1

PHARM

Citations per year, relative to Anne Marquet Anne Marquet (= 1×) peers Céline Desseille

Countries citing papers authored by Anne Marquet

Since Specialization

Citations

This map shows the geographic impact of Anne Marquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Marquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Marquet more than expected).

Fields of papers citing papers by Anne Marquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Marquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Marquet. The network helps show where Anne Marquet may publish in the future.

Co-authorship network of co-authors of Anne Marquet

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Marquet. A scholar is included among the top collaborators of Anne Marquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Marquet. Anne Marquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Guenther, Andreas, Birgit Jaber, Paul Jordan, et al.. (2018). A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier. British Journal of Clinical Pharmacology. 85(1). 181–193. 74 indexed citations

Kletzl, Heidemarie, Anne Marquet, Andreas Günther, et al.. (2018). The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy. Neuromuscular Disorders. 29(1). 21–29. 33 indexed citations

Chiriboga, Claudia A., Eugenio Mercuri, David F. Fischer, et al.. (2017). A series of case reports from JEWELFISH, an open-label study to investigate the safety, tolerability, and pharmacokinetics/ pharmacodynamics of RG7916 in adult and pediatric patients with spinal muscular atrophy who previously participated in a study with another SMN2-targeting therapy. Neuromuscular Disorders. 27. S209–S209.

Bonati, Leo H., Štefan Holiga, Nicole Hellbach, et al.. (2017). Longitudinal characterization of biomarkers for spinal muscular atrophy. Annals of Clinical and Translational Neurology. 4(5). 292–304. 40 indexed citations

Marquet, Anne, Heidemarie Kletzl, Andreas Günther, et al.. (2017). Oral SMN2 splicing modifiers in spinal muscular atrophy: Proof-of-mechanism and ongoing clinical studies. European Journal of Paediatric Neurology. 21. e226–e226. 1 indexed citations

Mercuri, Eugenio, Janbernd Kirschner, Giovanni Baranello, et al.. (2017). Clinical studies of RG7916 in patients with spinal muscular atrophy: SUNFISH part 1 study update. Neuromuscular Disorders. 27. S209–S209. 10 indexed citations

Chabanon, A., Yann Péréon, Aurore Daron, et al.. (2016). Baseline data from a European prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy – NatHis-SMA. Neuromuscular Disorders. 26. S103–S103. 2 indexed citations

Marquet, Anne, et al.. (2012). The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial. Clinical Pharmacology & Therapeutics. 92(4). 450–7. 30 indexed citations

Krösser, Sonja, et al.. (2012). Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects. Biopharmaceutics & Drug Disposition. 33(9). 550–559. 19 indexed citations

10.

Marquet, Anne, Vicente Larraga, José Luis Díez Gil, et al.. (1984). Immunogenicity of fatty acid anilides in rabbits and the pathogenesis of the Spanish toxic oil syndrome. Cellular and Molecular Life Sciences. 40(9). 977–980. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact